Author:
Foster Keith A.,Bigalke Hans,Aoki K. Roger
Publisher
Springer Science and Business Media LLC
Subject
Toxicology,General Neuroscience
Reference64 articles.
1. Aoki KR (2001) A comparison of the safety margins of botulinum neurotoxin serotypes A, B, and F in mice.Toxicon 39, 1815–1820.
2. Aoki KR (2002) Botulinum neurotoxin serotypes A and B preparations have different safety margins in preclinical models of muscle weakening efficacy and systemic safety.Toxicon 40, 923–928.
3. Aoki KR (2003) Evidence for antinociceptive activity of botulinum toxin type A in pain management.Headache 43, S9-S15.
4. Aoki KR, A Satorius, C Ardila, M Brown, G Nicholson G and J Francis (2005) Pharmacology of BOTOX®, Dysport®, Myobloc™ and BTX-A in animal models of efficacy and safety. 5th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins, Abstract 51, p. 59.
5. Apostolidis A, R Popat, Y Yiangou, D Cockayne, AP Ford, JB Davis, P Dasgupta, CJ Fowler and P Anand (2005) Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity.J. Urol. 174, 977–982.
Cited by
55 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献